ENGLISH      FRANÇAIS



Home / Online screening material / Histopathology of the uterine cervix - digital atlas / THE BETHESDA SYSTEM

Filter by language: English / Français / Portugues / 中文

  THE BETHESDA SYSTEM

SPECIMEN TYPE
Indicate
  • conventional smear (Pap smear)
  • vs. liquid-based preparation
  • vs. other.

SPECIMEN ADEQUACY
  • Satisfactory for evaluation (describe presence or absence of endocervical/transformation zone component and any other quality indicators, e.g., partially obscuring blood, inflammation, etc.)
  • Unsatisfactory for evaluation …(specify reason)
  • Specimen rejected/not processed (specify reason)
  • Specimen processed and examined, but unsatisfactory for evaluation of epithelial abnormality because of (specify reason)

GENERAL CATEGORIZATION (optional)

  • Negative for Intraepithelial Lesion or Malignancy
  • Other: See Interpretation/result (e.g., endometrial cells in a woman >= 40 years of age)
  • Epithelial Cell Abnormality: See Interpretation/result (specify ‘squamous’ or ‘glandular’ as appropriate)

INTERPRETATION/RESULT

NEGATIVE FOR INTRAEPITHELIAL LESION OR MALIGNANCY,
(when there is no cellular evidence of neoplasia, state this in the General Categorization above and/or in the Interpretation/Result section of the report, whether or not there are organisms or other non-neoplastic findings).
- ORGANISMS:
   * Trichomonas vaginalis
   * Fungal organisms morphologically consistent with Candida spp
   * Shift in flora suggestive of bacterial vaginosis
   * Bacteria morphologically consistent with Actinomyces spp.
   * Cellular changes consistent with Herpes simplex virus

- OTHER NON NEOPLASTIC FINDINGS (Optional to report; list not inclusive):
   * Reactive cellular changes associated with
      - inflammation (includes typical repair)
      - radiation
      - intrauterine contraceptive device (IUD)
   * Glandular cells status post hysterectomy
   * Atrophy

OTHER
- Endometrial cells (in a woman >= 40 years of age)
(Specify if ‘negative for squamous intraepithelial lesion’)


EPITHELIAL CELL ABNORMALITIES
- SQUAMOUS CELL
   * Atypical squamous cells
      - of undetermined significance (ASC-US)
      - cannot exclude HSIL (ASC-H)
   * Low grade squamous intraepithelial lesion (LSIL)
   (encompassing: HPV/mild dysplasia/CIN 1)
   * High grade squamous intraepithelial lesion (HSIL)
   (encompassing: moderate and severe dysplasia, CIS, CIN 2
   and CIN 3)
      - with features suspicious for invasion (if invasion
        is suspected)
   * Squamous cell carcinoma

- GLANDULAR CELL
   * Atypical
      - endocervical cells (not otherwise specified (NOS) or specify in comments),
      - endometrial cells (NOS or specify in comments),
      - glandular cells (NOS or specify in comments)
   * Atypical
      - endocervical cells, favor neoplastic
      - glandular cells, favor neoplastic
   * Endocervical adenocarcinoma in situ
   * Adenocarcinoma:
      - endocervical
      - endometrial
      - extrauterine
      - not otherwise specified (NOS)


OTHER MALIGNANT NEOPLASMS: (specify)



ANCILLARY TESTING

Provide a brief description of the test method(s) and report the result so that it is easily understood by the clinician.


AUTOMATED REVIEW

If case examined by automated device, specify device and result.


EDUCATIONAL NOTES AND SUGGESTIONS (optional)

Suggestions should be concise and consistent with clinical follow-up guidelines published by professional organizations (references to relevant publications may be included).
IARC, 150 Cours Albert Thomas, 69372 Lyon CEDEX 08, France - Tel: +33 (0)4 72 73 84 85 - Fax: +33 (0)4 72 73 85 75
© IARC 2014 - All Rights Reserved.